{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:23:40Z","timestamp":1792445020760,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ecl.2025.03.010","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:33:22Z","timestamp":1744878802000},"page":"397-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Evolving Role of Radioactive Iodine in Thyroid Cancer Diagnosis and Treatment"],"prefix":"10.1016","volume":"54","author":[{"given":"Kanchan","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca M.","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ecl.2025.03.010_bib1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ecl.2025.03.010_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1089\/thy.2022.0344","article-title":"Radioactive iodine: a living history","volume":"33","author":"Daniels","year":"2023","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.010_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ecl.2025.03.010_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2017.0434","article-title":"Location and causation of residual lymph node metastasis after surgical treatment of regionally advanced differentiated thyroid cancer","volume":"28","author":"Miller","year":"2018","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.010_bib5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.sla.0000250451.59685.67","article-title":"Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone","volume":"245","author":"Roh","year":"2007","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.010_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/bjs.8985","article-title":"Prophylactic central neck dissection for papillary thyroid cancer","volume":"100","author":"Barczynski","year":"2013","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.ecl.2025.03.010_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","article-title":"Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Haddad","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"issue":"12","key":"10.1016\/j.ecl.2025.03.010_bib8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1089\/thy.2009.1611","article-title":"The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer","volume":"19","author":"Van Nostrand","year":"2009","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.010_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.010_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0748-7983(97)92292-7","article-title":"The dynamics of serum thyroglobulin elimination from the body after thyroid surgery","volume":"23","author":"Hocevar","year":"1997","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.010_bib11","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s41598-020-80015-8","article-title":"A pre-ablative thyroid-stimulating hormone with 30-70 mIU\/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients","volume":"11","author":"Xiao","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.010_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MNM.0000000000000640","article-title":"Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma","volume":"38","author":"Lawal","year":"2017","journal-title":"Nucl Med Commun"},{"issue":"9","key":"10.1016\/j.ecl.2025.03.010_bib13","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1210\/JC.2015-1346","article-title":"Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS Registry Analysis 1987-2012","volume":"100","author":"Carhill","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2025.03.010_bib14","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2003-031167","article-title":"Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer","volume":"89","author":"Sawka","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.010_bib15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1210\/jc.2014-4332","article-title":"Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer","volume":"100","author":"Ruel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2025.03.010_bib16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/thy.2008.0339","article-title":"Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma","volume":"19","author":"Van Nostrand","year":"2009","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.010_bib17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/jc.2012-3630","article-title":"Preablation 131-I scans with SPECT\/CT in postoperative thyroid cancer patients: what is the impact on staging?","volume":"98","author":"Avram","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2025.03.010_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jso.24740","article-title":"Prognostic factors for recurrence of locally advanced differentiated thyroid cancer","volume":"116","author":"Kim","year":"2017","journal-title":"J Surg Oncol"},{"issue":"15","key":"10.1016\/j.ecl.2025.03.010_bib19","doi-asserted-by":"crossref","DOI":"10.21037\/atm-18-1301","article-title":"Prognostic factors and the effect of radioiodine on patients with locally advanced differentiated thyroid cancer","volume":"8","author":"Yao","year":"2020","journal-title":"Ann Transl Med"},{"issue":"7","key":"10.1016\/j.ecl.2025.03.010_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1089\/thy.2016.0650","article-title":"Comparison of survival outcomes following postsurgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma","volume":"27","author":"Yang","year":"2017","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ecl.2025.03.010_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.110.081059","article-title":"Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases","volume":"52","author":"Higashi","year":"2011","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.010_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/biomedicines12030532","article-title":"The effect of radioiodine therapy on the prognosis of differentiated thyroid cancer with lung metastases","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.ecl.2025.03.010_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20853","article-title":"Analysis of the clinical factors affecting excellent response of Iodine-131 treatment for pulmonary metastases from differentiated thyroid cancer","volume":"9","author":"Wu","year":"2023","journal-title":"Heliyon"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2025.03.010_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3329\/bjnm.v24i1-2.59334","article-title":"\u201cTherapeutic response and long-term outcome of differentiated thyroid cancer with pulmonary metastases treated by radioiodine therapy\u201d","volume":"24","author":"Ferdous","year":"2022","journal-title":"Bangladesh J Nucl Med"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.010_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-15-0296","article-title":"Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors","volume":"173","author":"Song","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2025.03.010_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2020.100282","article-title":"Bone metastases in thyroid cancer","volume":"21","author":"I\u00f1iguez-Ariza","year":"2020","journal-title":"J Bone Oncol"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.010_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000493190","article-title":"The impact of zoledronic acid and radioactive iodine therapy on morbi-mortality of patients with bone metastases of thyroid cancer derived from follicular cells","volume":"8","author":"Andrade","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ecl.2025.03.010_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40618-020-01374-7","article-title":"Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues","volume":"44","author":"Nervo","year":"2021","journal-title":"J Endocrinol Investig"},{"issue":"17","key":"10.1016\/j.ecl.2025.03.010_bib29","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.3390\/cancers13174429","article-title":"Current management of bone metastases from differentiated thyroid cancer","volume":"13","author":"Kato","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.010_bib30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2967\/jnumed.117.190819","article-title":"Current treatment strategies in metastasized differentiated thyroid cancer","volume":"60","author":"Kreissl","year":"2019","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.010_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/RLU.0000000000002321","article-title":"Differentiated thyroid cancer outcomes after surgery and activity-adjusted 131i theragnostics","volume":"44","author":"Avram","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.ecl.2025.03.010_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/thy.2011.0235","article-title":"Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin","volume":"22","author":"Klubo-Gwiezdzinska","year":"2012","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.ecl.2025.03.010_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/105072504322880373","article-title":"Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction","volume":"14","author":"Mendoza","year":"2004","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.010_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02984474","article-title":"Multifactorial analysis on the short-term side effects occurring within 96 hours after radioiodine-131 therapy for differentiated thyroid carcinoma","volume":"18","author":"Kita","year":"2004","journal-title":"Ann Nucl Med"},{"issue":"11","key":"10.1016\/j.ecl.2025.03.010_bib35","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/hed.26417","volume":"42","author":"Singer","year":"2020","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.ecl.2025.03.010_bib36","first-page":"21","article-title":"Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma","volume":"36","author":"Dottorini","year":"1995","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.ecl.2025.03.010_bib37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/MNM.0000000000000132","article-title":"Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma","volume":"35","author":"Fard-Esfahani","year":"2014","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.ecl.2025.03.010_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2967\/jnumed.107.049411","article-title":"Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine","volume":"49","author":"Silberstein","year":"2008","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.ecl.2025.03.010_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/thy.2012.0050","article-title":"Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin","volume":"23","author":"Rosario","year":"2013","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.ecl.2025.03.010_bib40","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00259-011-1841-x","article-title":"Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl","volume":"38","author":"Hebestreit","year":"2011","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ecl.2025.03.010_bib41","first-page":"171","article-title":"The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer","volume":"87","author":"Benua","year":"1962","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"11","key":"10.1016\/j.ecl.2025.03.010_bib42","first-page":"1797","article-title":"Iodine-131 in breast milk following therapy for thyroid carcinoma","volume":"35","author":"Robinson","year":"1994","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.ecl.2025.03.010_bib43","first-page":"2","article-title":"Breast uptake of radio-iodine in differentiated thyroid cancer","volume":"3","author":"Kulkarni","year":"2020","journal-title":"Science Repository"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:02:11Z","timestamp":1753484531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852925000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0889852925000325"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2025.03.010","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Evolving Role of Radioactive Iodine in Thyroid Cancer Diagnosis and Treatment","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2025.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}